CRECOG Trial

The CRECOG Trial – The effect of creatine monohydrate supplementation on cognitive function in older adults.

About this study

This research is the first study of its kind in New Zealand, where a team of scientists from Massey's College of Health will explore the effect of a nutritional supplement on cognitive function in older adults.

Our research will explore whether creatine monohydrate can improve cognitive function in older adults at an early stage. Your contribution to this scientific work will bring new insight into nutritional science and research.

New Zealand is reporting a growing number and high prevalence of Dementia and Alzheimer's in its ageing population. This study aims to bring some dimension to the prevention of these conditions and help keep brain health up to the mark during the crucial phase of life.

We welcome all interested participants to support our research into the effect of creatine monohydrate supplement on cognitive function in older adults.

Inclusion criteria

To apply to take part, you:

• are be 60 years of age or older
• may have some memory issues
• are fluent in English: spoken, written, listening/comprehension and reading
• live in Auckland.

You must not:

• be diagnosed with dementia, Alzheimer’s or Parkinsons
• be taking a creatine supplement currently
• have non-corrected visual or hearing conditions
• be participating or recently participated in another clinical study.

Your participation will involve 5 physical visits to the Nutrition Lab, IC Building, Massey University, Auckland, for cognitive function tests.

Incentives for participation

You will receive a $40 koha (gift) for each study visit, with a total maximum of $200.